Dubai UAE: Abdul Latif Jameel Health, part of international diversified family business Abdul Latif Jameel, and Cureleads, a Dubai, UAE and Beirut, Lebanon based pharmaceutical and medicinal distribution and marketing business working throughout the Middle East and North Africa, have announced a new agreement for the distribution of Butterfly Network, Inc.’s Butterfly iQ+ ultrasound solution in the UAE.

The innovative Butterfly iQ+ is the world's first single probe, whole-body handheld ultrasound solution that brings the power of ultrasound into assessment, diagnosis and treatment processes.

As part of its new agreement with Abdul Latif Jameel Health, Cureleads will register Butterfly iQ+ in the United Arab Emirates – already widely considered the healthcare hub for the Middle East – and start commercial sales in December 2022, bringing the technology to potentially more than 26,000 medical doctors practicing in public and private hospitals and facilities across the Emirates.

World Health Organization data suggests that over 4.7 billion people around the world lack access to medical imaging, from underserved communities in the United States to remote areas of Africa.  The Butterfly iQ+ aims to remedy this situation.  Fusing semiconductors and artificial intelligence, Butterfly has made it possible to usher in a new era of medical imaging and with it, transform healthcare.

With a very diverse populace, research estimates the UAE 2022 population at 10.08 million, more than double that in 2005 (4.58 million).  Government data reports that there are more than 200 nationalities living and working in the UAE.  Indians form the largest foreign community in the country, followed by Pakistanis, Bangladeshi, other Asians, Europeans, and Africans.

This new collaboration will offer greater distribution of Butterfly iQ+ to physicians in the UAE thereby expanding the capabilities of practitioners working both within, and outside, primary care units such as hospitals and clinics, accelerating access to modern medical care for those who need it most.

Butterfly iQ+, is revolutionizing medical imaging. It is an innovative 3 in 1, single-probe, whole-body hand-held ultrasound solution, powered by the world’s only Ultrasound–on-Chip™ technology.

This point of care device with over 20 default presets is compatible with both iOS and Android smart devices and comes complete with battery back, wireless charging, customized app software and AI support.

Hailed as potentially the ‘stethoscope of the future’, the Butterfly iQ+ transforms what can sometimes be complex processes, into one connected and integrated bedside imaging system.  Butterfly iQ+ uniquely unlocks access to ultrasound information at every point-of-care setting, no matter where that setting is.

Through this distribution, clinicians across the UAE will gain information they’ve never before had, empowering them to perform rapid assessments and to guide more informed clinical decision-making, diagnosis, and treatment.

“The Butterfly iQ+ is an innovative ultrasound solution which fits in the palm of a hand.  We’re very much looking forward to introducing the market to this technology and seeing how it can help every patient across the UAE, the hub for medical innovation in Middle East.”